Celldex Therapeutics, Inc. - Company Profile and SWOT Analysis
Summary
Celldex Therapeutics, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Celldex Therapeutics, Inc. (Celldex or 'the company') is a biopharmaceutical company that develops therapeutic monoclonal and bispecific antibodies for the treatment of inadequate diseases. The company is involved with human immune system which improves inflammatory diseases and many forms of cancer. It also develops therapies for patients with unmet medical needs. The company's major products in development include barzolvolimab CDX-0159 and CDX-622. It operates research laboratories in New Jersey, Massachusetts and Connecticut, the US. Celldex operates cGMP manufacturing facility in Fall River, Massachusetts, the US to produce drug substances for current and planned early-stage clinical trials. The company is headquartered in Hampton, New Jersey, the US.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook